Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Hepatology. 2022 Apr 7;75(6):1604–1626. doi: 10.1002/hep.32447

Figure 3. Strategies integrating ICI based on HCC stage currently under investigation.

Figure 3.

Combination strategies integrating ICI with surgical, locoregional, or other systemic therapies across HCC stages are depicted. ICI, immune checkpoint inhibition; VEGF, vascular endothelial growth factor. *Regulatory approval in the first line setting for advanced stage HCC. ** Met primary endpoint of OS in the first-line setting for advanced stage HCC.